Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage Reply

被引：0
|
作者：
Shoamanesh, Ashkan [1 ]
Sharma, Mukul [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：773 / 774
页数：2
相关论文
共 50 条
  • [21] Real world utilization of Andexanet alfa in the management of oral factor Xa inhibitor-associated gastrointestinal bleeding
    Brown, Caitlin S.
    Mattson, Alicia E.
    Cabrera, Daniel
    Coelho-Prabhu, Nayantara
    Rabinstein, Alejandro A.
    Dettling, Theresa
    McBane II, Robert D.
    Bellolio, Fernanda
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 73 : 1 - 6
  • [22] Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study
    Singer, Adam J.
    Concha, Mauricio
    Williams, James
    Brown, Caitlin S.
    Fernandes, Rafael
    Thode, Henry C., Jr.
    Kirchman, Marylin
    Rabinstein, Alejandro A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2023, 24 (05) : 939 - 949
  • [23] Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies
    Ferreira, Luan Oliveira
    Oldemburg, Ricardo Andres Leon
    Leitao Filho, Joao Monteiro
    Cerveira, Rodrigo Arcoverde
    Vasconcelos, Victoria Winkler
    da Costa, Giovana Escribano
    Rodrigues, Roseny dos Reis
    Lopes, Dielly Catrina Favacho
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [24] Concomitant andexanet alfa and 4 F-PCC for Factor Xa inhibitor associated intracranial hemorrhage
    Orban III, James E.
    Ruckel, Cassidy
    Harlan, Sarah
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 233
  • [25] Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series
    Liu, JiTong
    Elsamadisi, Pansy
    Philips, Eli
    Bauer, Kenneth A.
    Eche, Ifeoma M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (16) : 1323 - 1329
  • [26] Andexanet Alfa for Factor Xa Inhibitor Reversal
    Shatzel, Joseph J.
    Daughety, Molly M.
    DeLoughery, Thomas G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (25): : 2499 - 2499
  • [27] A Tertiary Care Center's Experience with Andexanet Alfa for Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage
    Smith, Matthew
    Beatty, Julia
    Keegan, Shaun
    Robinson, David
    Walsh, Kyle
    Garber, Paige
    NEUROLOGY, 2019, 92 (15)
  • [28] Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
    Connolly, Stuart J.
    Milling, Truman J., Jr.
    Eikelboom, John W.
    Gibson, C. Michael
    Curnutte, John T.
    Gold, Alex
    Bronson, Michele D.
    Lu, Genmin
    Conley, Pamela B.
    Verhamme, Peter
    Schmidt, Jeannot
    Middeldorp, Saskia
    Cohen, Alexander T.
    Beyer-Westendorf, Jan
    Albaladejo, Pierre
    Lopez-Sendon, Jose
    Goodman, Shelly
    Leeds, Janet
    Wiens, Brian L.
    Siegal, Deborah M.
    Zotova, Elena
    Meeks, Brandi
    Nakamya, Juliet
    Lim, W. Ting
    Crowther, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (12): : 1131 - 1141
  • [29] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
    Siegal, Deborah M.
    Curnutte, John T.
    Connolly, Stuart J.
    Lu, Genmin
    Conley, Pamela B.
    Wiens, Brian L.
    Mathur, Vandana S.
    Castillo, Janice
    Bronson, Michele D.
    Leeds, Janet M.
    Mar, Florie A.
    Gold, Alex
    Crowther, Mark A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2413 - 2424
  • [30] COST COMPARISON OF ANDEXANET VERSUS PCC FOR DIRECT FACTOR XA INHIBITOR REVERSAL AFTER HEMORRHAGE
    Frontera, Jennier
    Joset, Danielle
    Lalchan, Rebecca
    Ahuja, Tania
    Papadopoulis, John
    CRITICAL CARE MEDICINE, 2019, 47
12345